Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Calvert

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Folate-based thymidylate synthase inhibitors as anticancer drugsA L Jackman, A H Calvert
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologiesA H Calvert, M J Egorin
Cancer Chemotherapy and Pharmacology|January 1, 1996
A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curveS Ghazal-Aswad, A H Calvert, D R Newell
Journal of Chromatography|June 30, 1989
Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatographyM A Graham, D R Newell, A H Calvert
Cancer Treatment Reports|December 1, 1977
Some observations on the human pharmacology of methotrexateA H Calvert, P K Bondy, K R Harrap
European Journal of Cancer & Clinical Oncology|September 1, 1987
High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation studyM E Gore, A H Calvert, L E Smith
Biochemical Pharmacology|December 15, 1983
Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cellsR C Jackson, A L Jackman, A H Calvert
Seminars in Oncology|February 1, 1992
Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin?A H Calvert, D R Newell, M E Gore
Journal of Clinical Pathology|December 1, 1977
An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494)A H Calvert, J S Cridland, K R Harrap
Biochemical Pharmacology|November 1, 1988
Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitroE Sikora, A L Jackman, D R Newell, et al.
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Folate-based thymidylate synthase inhibitors as anticancer drugsA L Jackman, A H Calvert
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologiesA H Calvert, M J Egorin
Cancer Chemotherapy and Pharmacology|January 1, 1996
A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curveS Ghazal-Aswad, A H Calvert, D R Newell
Journal of Chromatography|June 30, 1989
Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatographyM A Graham, D R Newell, A H Calvert
Cancer Treatment Reports|December 1, 1977
Some observations on the human pharmacology of methotrexateA H Calvert, P K Bondy, K R Harrap
European Journal of Cancer & Clinical Oncology|September 1, 1987
High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation studyM E Gore, A H Calvert, L E Smith
Biochemical Pharmacology|December 15, 1983
Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cellsR C Jackson, A L Jackman, A H Calvert
Seminars in Oncology|February 1, 1992
Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin?A H Calvert, D R Newell, M E Gore
Journal of Clinical Pathology|December 1, 1977
An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494)A H Calvert, J S Cridland, K R Harrap
Biochemical Pharmacology|November 1, 1988
Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitroE Sikora, A L Jackman, D R Newell, et al.
Pageof 15